Anthera Pharmaceuticals, Inc.
ANTH · OTC
3/31/2018 | 12/31/2017 | 9/30/2017 | 6/30/2017 | |
|---|---|---|---|---|
| Market Cap | $7 | $24 | $16 | $16 |
| - Cash | $8 | $2 | $6 | $11 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$1 | $21 | $10 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$9 | -$8 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$10 | -$5 | $9 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.2 | -0.76 | -0.43 | 0.92 |
| % Growth | 73.7% | -76.7% | -146.7% | – |
| Operating Cash Flow | -$9 | -$6 | -$6 | -$10 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$9 | -$6 | -$6 | -$10 |